Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 1,135.00
-23.00 (-1.99%)
Sep 19, 2025, 2:35 PM KST
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 89.90 billion as of September 18, 2025. Its market cap has decreased by -32.17% in one year.
Market Cap
89.90B
Enterprise Value
-17.05B
Revenue
72.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,135.00
Market Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 89.90B, a decrease of -58.66%. That is a compound annual growth rate of -9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 89.90B | -20.98% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | 869.25B | 57.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.59T |
| Celltrion | 37.16T |
| ALTEOGEN | 26.27T |
| Yuhan | 8,924.87B |
| SK Biopharmaceuticals | 8,669.28B |
| Peptron | 6,977.56B |
| PharmaResearch | 6,524.70B |
| LigaChem Biosciences | 5,592.86B |